β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer (original) (raw)

• Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011).
  Article PubMed Google Scholar
• Jänne, P.A. & Mayer, R.J. Chemoprevention of colorectal cancer. N. Engl. J. Med. 342, 1960–1968 (2000).
  Article PubMed Google Scholar
• Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 127, 469–480 (2006).
  Article CAS Google Scholar
• Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843–850 (2005).
  Article CAS Google Scholar
• Pálmer, H.G. et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol. 154, 369–387 (2001).
  Article PubMed Google Scholar
• Olson, L.E. et al. Homeodomain-mediated β-catenin-dependent switching events dictate cell-lineage determination. Cell 125, 593–605 (2006).
  Article CAS PubMed Google Scholar
• Pálmer, H.G., Anjos-Afonso, F., Carmeliet, G., Takeda, H. & Watt, F.M. The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis. PLoS ONE 3, e1483 (2008).
  Article PubMed Google Scholar
• Essers, M.A. et al. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308, 1181–1184 (2005).
  Article CAS PubMed Google Scholar
• Calnan, D.R. & Brunet, A. The FoxO code. Oncogene 27, 2276–2288 (2008).
  Article CAS Google Scholar
• van der Horst, A. & Burgering, B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440–450 (2007).
  Article CAS PubMed Google Scholar
• Myatt, S.S. & Lam, E.W. The emerging roles of forkhead box (Fox) proteins in cancer. Nat. Rev. Cancer 7, 847–859 (2007).
  Article CAS PubMed Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999).
  Article CAS Google Scholar
• Dehner, M., Hadjihannas, M., Weiske, J., Huber, O. & Behrens, J. Wnt signaling inhibits Forkhead box O3a–induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1. J. Biol. Chem. 283, 19201–19210 (2008).
  Article CAS PubMed Google Scholar
• Walther, A. et al. Genetic prognostic and predictive markers in colorectal cancer. Nat. Rev. Cancer 9, 489–499 (2009).
  Article CAS PubMed Google Scholar
• Dienstmann, R., Rodon, J., Markman, B. & Tabernero, J. Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2. Recent Pat. Anticancer. Drug Discov. 6, 210–236 (2011).
  Article CAS PubMed Google Scholar
• Yang, L. et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 64, 4394–4399 (2004).
  Article CAS PubMed Google Scholar
• Zheng, Y. et al. Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone. J Mol Med (Berl) (2011).
• Liu, P., Cheng, H., Roberts, T.M. & Zhao, J.J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8, 627–644 (2009).
  Article CAS PubMed Google Scholar
• Hoffman, K. et al. Phase I–II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. Cancer Chemother. Pharmacol. 37, 254–258 (1996).
  Article CAS PubMed Google Scholar
• Bendell, J.C. et al. Phase I, dose-escalation study of BKM120, an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors. J. Clin. Oncol. 30, 282–290 (2012).
  Article CAS PubMed Google Scholar
• Dijkers, P.F., Medema, R.H., Lammers, J.W., Koenderman, L. & Coffer, P.J. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr. Biol. 10, 1201–1204 (2000).
  Article CAS PubMed Google Scholar
• Seoane, J., Le, H.V., Shen, L., Anderson, S.A. & Massague, J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211–223 (2004).
  Article CAS Google Scholar
• Hoogeboom, D. et al. Interaction of FOXO with β-catenin inhibits β-catenin/T cell factor activity. J. Biol. Chem. 283, 9224–9230 (2008).
  Article CAS PubMed Google Scholar
• Kops, G.J. et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316–321 (2002).
  Article CAS Google Scholar
• Brabletz, T. et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 98, 10356–10361 (2001).
  Article CAS PubMed Google Scholar
• Delpuech, O. et al. Induction of Mxi1-SR α by FOXO3a contributes to repression of Myc-dependent gene expression. Mol. Cell. Biol. 27, 4917–4930 (2007).
  Article CAS PubMed Google Scholar
• Wells, C.D. et al. A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells. Cell 125, 535–548 (2006).
  Article CAS Google Scholar
• Yamashiro, S., Abe, H. & Mabuchi, I. IQGAP2 is required for the cadherin-mediated cell-to-cell adhesion in Xenopus laevis embryos. Dev. Biol. 308, 485–493 (2007).
  Article CAS PubMed Google Scholar
• Natale, D.R. & Watson, A.J. Rac-1 and IQGAP are potential regulators of E-cadherin-catenin interactions during murine preimplantation development. Gene Expr. Patterns 2, 17–22 (2002).
  Article CAS PubMed Google Scholar
• Tsai, M.S., Hornby, A.E., Lakins, J. & Lupu, R. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res. 60, 5603–5607 (2000).
  CAS PubMed Google Scholar
• Dhawan, P. et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest. 115, 1765–1776 (2005).
  Article CAS PubMed Google Scholar
• Huang, S.M. et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614–620 (2009).
  Article CAS Google Scholar
• Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785–789 (1995).
  Article CAS PubMed Google Scholar
• Brabletz, T., Jung, A., Dag, S., Hlubek, F. & Kirchner, T. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155, 1033–1038 (1999).
  Article CAS PubMed Google Scholar
• Samuels, Y. et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7, 561–573 (2005).
  Article CAS PubMed Google Scholar
• Yoeli-Lerner, M. et al. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol. Cell 20, 539–550 (2005).
  Article CAS PubMed Google Scholar
• Chen, J. et al. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer. PLoS ONE 5, e12293 (2010).
  Article PubMed Google Scholar
• Storz, P., Doppler, H., Copland, J.A., Simpson, K.J. & Toker, A. FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. Mol. Cell. Biol. 29, 4906–4917 (2009).
  Article CAS PubMed Google Scholar
• Paik, J.H. et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128, 309–323 (2007).
  Article CAS PubMed Google Scholar
• Jun, T., Gjoerup, O. & Roberts, T.M. Tangled webs: evidence of cross-talk between c-Raf-1 and Akt. Sci. STKE 1999, PE1 (1999).
  CAS PubMed Google Scholar
• Zunder, E.R., Knight, Z.A., Houseman, B.T., Apsel, B. & Shokat, K.M. Discovery of drug-resistant and drug-sensitizing mutations in the oncogenic PI3K isoform p110 α. Cancer Cell 14, 180–192 (2008).
  Article CAS PubMed Google Scholar
• Gomes, A.R., Brosens, J.J. & Lam, E.W. Resist or die: FOXO transcription factors determine the cellular response to chemotherapy. Cell Cycle 7, 3133–3136 (2008).
  Article CAS PubMed Google Scholar
• Obexer, P., Geiger, K., Ambros, P.F., Meister, B. & Ausserlechner, M.J. FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14, 534–547 (2007).
  Article CAS PubMed Google Scholar
• Rochat-Steiner, V. et al. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J. Exp. Med. 192, 1165–1174 (2000).
  Article CAS PubMed Google Scholar
• Tourneur, L. & Chiocchia, G. FADD: a regulator of life and death. Trends Immunol. 31, 260–269 (2010).
  Article CAS PubMed Google Scholar
• Shackleton, M., Quintana, E., Fearon, E.R. & Morrison, S.J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822–829 (2009).
  Article CAS PubMed Google Scholar
• Fodde, R. & Brabletz, T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19, 150–158 (2007).
  Article CAS PubMed Google Scholar
• Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313–319 (2011).
  Article CAS Google Scholar
• Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468–476 (2010).
  Article CAS PubMed Google Scholar
• Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744–749 (2005).
  Article CAS PubMed Google Scholar
• Todaro, M. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389–402 (2007).
  Article CAS PubMed Google Scholar
• Van der Flier, L.G. et al. The intestinal Wnt/TCF signature. Gastroenterology 132, 628–632 (2007).
  Article CAS PubMed Google Scholar
• Kreso, A. & O'Brien, C.A. Colon cancer stem cells. Curr. Protoc. Stem Cell Biol. 7, 3.1.1–3.1.12 (2008).
  Google Scholar
• Céspedes, M.V. et al. Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites. Am. J. Pathol. 170, 1077–1085 (2007).
  Article PubMed Google Scholar
• Ueno, H., Murphy, J., Jass, J.R., Mochizuki, H. & Talbot, I.C. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40, 127–132 (2002).
  Article CAS PubMed Google Scholar
• Barbáchano, A. et al. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene 29, 4800–4813 (2010).
  Article PubMed Google Scholar
• Arques, O., Chicote, I., Tenbaum, S., Puig, I. & Palmer, H.G. Standardized relative quantification of immunofluorescence tissue staining. Protoc. Exchange published online, doi:10.1038/protex.2012.008 (2 April 2012).
• Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).
  Article PubMed Google Scholar
• Aguilar, S. et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 4, e8013 (2009).
  Article PubMed Google Scholar
• Barde, I. et al. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol. Ther. 13, 382–390 (2006).
  Article CAS PubMed Google Scholar
• Fuerer, C. & Nusse, R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS ONE 5, e9370 (2010).
  Article PubMed Google Scholar